Enrolling
Eli Lilly ITSW
Eli Lilly ITSW
This is a study of LY900014 in participants with Type 2 Diabetes using Continuous Glucose Monitoring.
Type 2 Diabetes
Enrolling
SURPASS-6
SURPASS-6
This trial compares the efficacy and safety of tirzepatide once weekly at either 5 mg, 10 mg, 15 mg dose to 3 times a day Lispro in patients with type 2 diabetes on glargine.
Enrolling
Eli Lilly BDCL
Eli Lilly BDCL
The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes.
On Hold
NN4650
NN4650
The Sustain Switch trial compares the effect and safety of 2 different dose schedules for semaglutide (study medicine) in people with type 2 diabetes previously treated with a diabetes medicine similar to semaglutide.
Enrolling
Semaglutide
Semaglutide
Semaglutide Cardiovascular Outcomes Trial in Patients With Type 2 Diabetes.
On Hold
RLM-MD Study
RLM-MD Study
A 52-week study that compares the efficacy of Relamorelin with that of placebo in participants with diabetic gastroparesis with respect to the core signs and symptoms of diabetic gastroparesis.
Can’t find a study that works for you?
Subscribe for Information on Other Studies
Fill out the form below an we will let you know when a study becomes available that you may be interested in:
